Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating activities
Net income	$ 20,019	$ 8,799
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	2,726	1,383
Stock-based compensation expense	2,516	1,911
Deferred income taxes	(2,808)	(1,331)
Distribution of income from unconsolidated subsidiaries	3,460	852
Equity in income of unconsolidated subsidiaries	(3,168)	(1,255)
(Gain) loss on disposition of assets	259	59
Changes in assets and liabilities:
Cash held in escrow	16,188	2,828
Accounts receivable	994	(1,309)
Inventories	(82,377)	(21,254)
Prepaid expenses and other assets	56	393
Accounts payable	(1,637)	(7,429)
Accrued expenses and other liabilities	(12,947)	6,237
Mortgage loans held for sale	12,148
Net cash used in operating activities	(44,571)	(10,116)
Investing activities
Purchases of property and equipment	(2,370)	(1,052)
Other investing activities	295	25
Net cash used in investing activities	(2,075)	(1,027)
Financing activities
Borrowings under revolving credit facilities	60,000	45,000
Payments on revolving credit facilities	(60,000)	(175,000)
Proceeds from issuance of senior notes		127,500
Principal payments on notes payable		(1,582)
Debt issuance costs		(2,533)
Net proceeds from mortgage repurchase facilities	(11,307)
Net proceeds from issuances of common stock	5,021	15,023
Repurchases of common stock upon vesting of stock based compensation	(4,790)	(2,904)
Net cash provided by (used in) financing activities	(11,076)	5,504
Net decrease	(57,722)	(5,639)
Cash and cash equivalents and Restricted cash, Beginning of period	93,713	30,954
Cash and cash equivalents and Restricted cash, End of period	35,991	25,315
Supplemental cash flow disclosure
Cash paid for income taxes	606
Cash and cash equivalents and Restricted cash
Cash and cash equivalents and Restricted cash	$ 93,713	$ 30,954